Endobronchial ultrasound biopsy devices market to reach $925.2m by 2030

It is expected to grow at a 4.3% CAGR.

The global market for endobronchial ultrasound (EBUS) biopsy devices is expected to reach $925.2m by 2030 at a compound annual growth rate of 4.3%, according to Research and Markets.

The sector’s expansion is attributed to the increasing prevalence of lung diseases and the demand for early and accurate diagnosis.

Moreover, the rising incidence of lung cancer has further driven the demand for EBUS biopsy devices.

“Technological advancements, such as high-resolution imaging and AI-assisted navigation, are also propelling market growth,” the report said.